Research Articles
Application of Logistic Growth Model to Pharmacodynamic Analysis of in Vitro Bactericidal Kinetics

https://doi.org/10.1021/js9801337Get rights and content

Abstract

A new pharmacodynamic model for the analysis of in vitro bactericidal kinetics was developed based on the logistic growth model, with the bacterial phases divided into two compartments. The model equations are expressed as nonlinear simultaneous differential equations, and the Runge–Kutta–Gill method was adopted to numerically solve the equations in both the simulation and the least squares curve-fitting procedures. The model can describe the initial killing and the regrowth phases and can explain the nonlinear dependence of the killing rate on the drug concentration. The model can also explain the plateau in the bacterial growth curve that is often observed in in vitro experiments. The model was applied to analysis of the in vitro time-killing data of β-lactam antibiotics, S-4661, meropenem, imipenem, cefpirome, and ceftazidim against three types of bacteria, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The results of curve-fitting using the least squares program MULTI (Runge) showed good fits for all types of drugs and bacteria. The relationship between the characteristics of the drug–bacteria interactions and the estimated pharmacodynamic parameters is discussed.

References and Notes (22)

  • S. Hamano et al.

    Kinetic Analysis and Characterization of the Bacterial Regrowth after Treatment of

    Escherichia coli with β-Lactam Antibiotics. J. Pharm. Sci.

    (1984)
  • R.C. Li et al.

    Pharmacodynamic Modeling of Bacterial Kinetics: β-Lactam Antibiotics against

    Escherichia coli. J. Pharm. Sci.

    (1994)
  • W.A. Craig et al.

    Killing and Regrowth of Bacteria in Vitro: A Review

    Scand. J. Infect. Dis.

    (1991)
  • Somberg, J. C., Clinical Therapeutic Conference. Conference Editorial...
  • A. Tsuji et al.

    Microbial Kinetics of β-Lactam Antibiotics against

    Escherichia coli. J. Pharm. Sci.

    (1984)
  • G. Carret et al.

    Biphasic Kinetics of Bacterial Killing by Quinolones

    J. Antimicrob. Chemother.

    (1991)
  • R.C. Li et al.

    Nix, D. E. The Fractional Maximum Effect Method: A New Way to Characterize the Effect of Antibiotic Combinations and Other Nonlinear Pharmacody-namic Interactions

    Antimicrob. Agents Chemother.

    (1993)
  • Mattie, M. Kinetic of Antimicrobial Action

    Rev. Infect. Dis.

    (1981)
  • A. Nolting et al.

    Pharmacokinetic-Pharmacodynamic Modeling of the Antibiotics Effect of Piperacillin in Vitro

    Pharm. Res.

    (1996)
  • T.D. Costa et al.

    Pharmacokinetic-Pharmacodynamic Modeling of the in vitro Antiinfective Effect of piperacillin-Tazobactam Combinations

    Int. J. Clin. Pharmacol. Ther.

    (1997)
  • R. Haberman

    Mathematical Model

    Population Dynamics

    (1977)
  • Cited by (0)

    Discovery Research Laboratories II, Shionogi & Co., Ltd., Osaka, Japan.

    Developmental Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

    View full text